Recap: Adamis Pharmaceuticals Q2 Earnings



Adamis Pharmaceuticals ADMP reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.


Adamis Pharmaceuticals missed estimated earnings by 100.0%, reporting an EPS of $-0.06 versus an estimate of $-0.03.

Revenue was down $3.97 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 8.03% drop in the share price the next day.


To track all earnings releases for Adamis Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


Image and article originally from Read the original article here.